REACTIONS
Dr. Manjunath.G.N
SSMC
Tumkur
Definition
• Any response to a drug that is
noxious and unintended and that
occurs at doses used in man.
Types
• Dose related (Predictable – type A)
• Non dose related (Unpredictable –
type B)
• Long term effects
• Delayed effects
Severity
• Mild
• Moderate
• Severe
• Lethal
Incidence
• Hospital in-patients – 10-20%
• Deaths in hospital in-patients - 0.24-
2.9%
• Hospital admissions – 0.3-5%
Classification of ADR
• Dose related
1.Pharmaceutical variation
2.Pharmacokinetic variation
a) Pharmacogenetic variation
b) Hepatic disease
c) Renal disease
d) Cardiac disease
3.Pharmacodynamic variation
a) Hepatic disease
b) Altered fluid and electrolyte imbalance
Contd.
• Non dose related
a) Immunological reaction
b) Pharmacogenetic variation
• Long term effects
a) Adaptive changes
b) Rebound phenomena
c) Other long term effects
Contd.
• Delayed effects
a) Carcinogenesis
b) Effects connected with reproduction
a) Impaired infertility
b) Teratogenesis
c) Drugs in breast milk
Various ADR
• Side effects
• Secondary effects
• Toxic effects
• Intolerance
– quantitative
- qualitative 1. Idiosyncracy
2. Hypersensitivity
• Photosensitization
Contd.
• Drug withdrawal reaction
• Drug dependence
• Teratogenecity
• Carcinogenecity/mutagenecity
• Iatrogenecity
Manifestations of ADR
• Haemopoietic toxicity
• Hepatotoxicty- direct
immunological
• Nephrotoxicity
• Ocular toxicity
• Ototoxicity
Contd.
• Behavioural toxicity
• Electrolyte imbalance
• Endocrine disturbance
• Skin toxicity
• Unmasking and exacerbation of
disease
• Acute withdrawal reaction
Contd.
• Carcinogenesis
• Teratogenesis
• Alteration of taste
• Drug dependance
Pharmacovigilance
widening horizons
• Illegal sale of medicines and drugs of
abuse on internet
• Increasing self medication practices
• Widespread manufacture and sale of
counterfeit and substandard medicines
• Increasing use of traditional medicines
outside the confines of traditional culture
• Increasing use of traditional medicines and
herbal medicines with other medicines
Pharmacovigilance
• French term- detection, assessment,
understanding and prevention of
adverse drug event
Partners in
pharmacovigilance
• WHO quality assurance and
safety;medicines team
• Uppasala monitoring center
• National pharmacovigilance centers
• Pharmaceutical industry
• Hospitals
• Health professional
• Patients
• Other partners
What is ADR
monitoring ?
• Systemically collecting information
about adverse drug experiences with
the aim of, through feed back to the
parties involved, contribute to
continuously improving drug therapy.
Aim : To detect
• Serious unexpected ADRs
• Increased or unexpectedly high
frequency of known significant ADRs
• To prepare list of ADRs not
previously reported
• To disseminate the information
through regular bulletins, reports,
and articles in the press
Surveillance methods
• Anecdotal reporting
• Voluntary reporting
• Intensive event reporting
• Cohort studies
• Case control studies
• Population statistics
• Record linkage
• Meta analysis
Need for monitoring
• Short coming of premarketing studies-which
reveal most common and acute untoward effect
• Increase cost of patient care
• Medication : 10-57% is self medication
• Our country has vast population, poverty and rich
research ground
• Accelerated approval and rapid introduction of
new drugs
• Paucity of ADR data
Who reports ?
• Doctors-hospital level, Medical
officer from PHC’s, GP’s
• Dentists
• Drug manufacturers
• Pharmacists and nurses
Types of ADR
Type Type of effect Features examples
A Augmented Common, predictable, low mortality Bradycardia–β-blockers